David P. Luci is CEO & President at Acurx Pharmaceuticals, Inc. (ACXP). They have made 7 open-market trades across 4 companies since 2006, most recently 2025-01-06.
CIK 0001271123
5 open-market purchases totalling $302K since 2007, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACXP | BUY | 2025-01-06 | 2025-01-08 | $1.02 | $100K | +6.8% | -2.5% | -61.6% |
| ACXP | BUY | 2022-07-27 | 2022-07-29 | $3.80 | $150K | +31.3% | -6.6% | -13.2% |
| ACXP | BUY | 2021-11-19 | 2021-11-22 | $4.80 | $25K | -13.4% | -4.6% | -16.5% |
| DPRX | BUY | 2014-03-18 | 2014-03-19 | $12.00 | $25K | N/A | N/A | N/A |
| MACM.OB | BUY | 2007-12-31 | 2008-01-04 | $0.59 | $2K | N/A | N/A | N/A |
| BIV | SELL | 2006-03-06 | 2006-03-07 | $7.96 | $1.1M | N/A | N/A | N/A |
| BIV | SELL | 2006-02-28 | 2006-03-02 | $8.57 | $557K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.